Emerging studies suggest potential benefits in cardiovascular risk reduction, non-alcoholic fatty liver disease (NAFLD), and metabolic syndrome, positioning Semaglutide as a versatile therapeutic agent in endocrine and metabolic disorders
Short-chain fatty acids and insulin sensitivity: a systematic review and meta-analysis
Always consult with a healthcare provider before making any changes to medication or if any new symptoms or concerns arise
The pills are quite small, which is a plus considering swallowing
Over time, high blood sugar levels can damage the bodys tissues and organs, leading to various health problems and a shortened lifespan
doi:10.1200/JCO.2026.44.19_suppl.138 Jajja S, Thukral J, Abdalla A, et al